Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Pt reports having had been vaccinated for covid in Apr and May but getting covid in Aug2021; Pt reports having had been vaccinated for covid in Apr and May but getting covid in Aug2021; This is a spontaneous report received via Pfizer-sponsored program from contactable other HCP (nurse) and a contactable 81-year-old female consumer (patient). A 81-year-old female patient received bnt162b2 (COMIRNATY- formulation: solution for injection), DOSE 2 via an unspecified route of administration in May2021 (Batch/Lot Number: unknown) as dose 2, single and received DOSE 1 via an unspecified route of administration in Apr2021 (Batch/Lot Number: unknown) as dose 1, single for covid-19 immunisation (at age of 80 years). It was reported that patient also took Tafamidis (VYNDAMAX,61 mg, daily (1 CAPSULE) from the month of Oct2006 as a co-suspect for the indication of Transthyretin-mediated amyloidosis cardiomyopathy. The patient medical history had included Anxiety disorder, Benign hypertension, Chronic angle-closure Glaucoma, Chronic diastolic (congestive) Heart failure, Hyperlipidaemia and allergy of Amlodipine, Amoxicillin, Bactrum, Bleph-10, Crestor, Lipitor, Penicillin V Potassium and Septra. Concomitant medication(s) included calcium carbonate (CALCIUM CARBONATE) taken for an unspecified indication, start and stop date were not reported; ascorbic acid, betacarotene, biotin, calcium, chlorine, chromium, copper, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon, thiamine, vanadium, vitamin d nos, xantofyl, zinc (CENTRUM SILVER +50) taken for an unspecified indication, start and stop date were not reported; doxazosin mesylate (DOXAZOSIN MESYLATE) taken for an unspecified indication, start and stop date were not reported; fish oil (FISH OIL) taken for an unspecified indication, start and stop date were not reported; lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; ascorbic acid (VITAMIN C ACID) taken for an unspecified indication, start and stop date were not reported; tocopheryl acetate (VITAMIN E NATURAL WEALTH) taken for an unspecified indication, start and stop date were not reported; ezetimibe (ZETIA) taken for an unspecified indication, start and stop date were not reported; verapamil hcl (VERAPAMIL HCL) taken for an unspecified indication, start and stop date were not reported; ezetimibe (EZETIMIBE) taken for an unspecified indication, start and stop date were not reported; carvedilol (CARVEDILOL) taken for an unspecified indication, start and stop date were not reported; hydralazine hcl (HYDRALAZINE HCL) taken for an unspecified indication, start and stop date were not reported; torsemide (TORSEMIDE) taken for an unspecified indication, start and stop date were not reported; metoprolol tartrate (METOPROLOL TARTRATE) taken for an unspecified indication, start and stop date were not reported. The patient previously took amlodipine and experienced drug hypersensitivity, amoxicillin and experienced drug hypersensitivity, bleph and experienced drug hypersensitivity, bactrim and experienced drug hypersensitivity. On Aug2021 the patient had experienced getting COVID. The outcome of the events was reported as unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.